Translational Pathways

Chair: University of Nottingham

This cluster ensures that findings from the RADAR-CNS (Remote Assessment of Disease and Relapse – Central Nervous System) Clinical Disorders and Technical Platforms clusters are translated efficiently and effectively into real-world clinical applications. We aim to have workable clinical devices entering health services by 2020.  To achieve this, we need to understand and learn from the needs of patients, clinical services and regulators.

Patient Involvement (Work Package 2)

Works with patient stakeholders to understand issues such as privacy, usability, and acceptability of remote measurement technologies. Also works to identify clinical endpoints which are most relevant to patients, and identify facilitators and challenges for engagement and adherence that can be further tested in this project.

Clinical Pathways (Work Package 9)

Identifies the requirements of clinical stakeholders (healthcare professionals, managers, commissioners and payers) for integrating remote measurement technologies into care pathways for depression, epilepsy, and multiple sclerosis (MS) in different European healthcare systems. Provides a structure so that these requirements form a coherent contribution to the project system specification to ensure its maximum applicability, acceptability and adoption in healthcare systems.

Regulation (Work Package 10)

Works with EU medical device and product regulators to understand their requirements in this field. Provides a structure to ensure that the regulatory learning during the project is collected and integrated to ensure its maximum applicability, acceptability and adoption.  This work package will provide a framework for the classification of remote measurement technologies as medical devices or otherwise, and will also identify what kind of information is needed for regulatory approval.